London & Capital Asset Management’s Pfizer PFE Stock Holding History

London & Capital Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,685	Closed	-$272K	–	227
2026 Q1	$272K	Sell	9,685 -310	-3%	-$8.25K	﹤0.01%	204
2025 Q4	$249K	Buy	+9,995	New	+$252K	﹤0.01%	219
2020 Q3	–	Sell	-9,367	Closed	-$291K	–	95
2020 Q2	$291K	Sell	9,367 -1,367	-13%	-$46.4K	0.05%	89
2020 Q1	$332K	Sell	10,734 -205	-2%	-$6.99K	0.08%	61
2019 Q4	$407K	Sell	10,939 -1,603	-13%	-$57.1K	0.07%	71
2019 Q3	$428K	Buy	12,542 +935	+8%	+$34K	0.07%	66
2019 Q2	$477K	Sell	11,607 -447	-4%	-$17.8K	0.1%	66
2019 Q1	$486K	Hold	12,054	–	–	0.07%	59
2018 Q4	$499K	Buy	+12,054	New	+$500K	0.08%	65

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

London & Capital Asset Management's PFE Position: Q2 2026 in Review

London & Capital Asset Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 9,685 shares — an estimated $272K sold.

London & Capital Asset Management first reported a position in PFE in Q4 2018 and held it in 9 quarters. The position peaked at $499K in Q4 2018. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

London & Capital Asset Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
London & Capital Asset Management sold 9,685 Pfizer shares in Q2 2026, an estimated $272K.
London & Capital Asset Management first reported a position in Pfizer in Q4 2018 and held it in 9 quarters.
London & Capital Asset Management's Pfizer position peaked at $499K in Q4 2018.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on London & Capital Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.